Finding 496816 (2023-003)

Material Weakness
Requirement
N
Questioned Costs
-
Year
2023
Accepted
2024-09-13
Audit: 319544

AI Summary

  • Core Issue: Texas Biomed failed to obtain required weekly certified payrolls from contractors, violating wage rate requirements for federally funded construction projects.
  • Impacted Requirements: Non-compliance with 2 CFR 200.303(a) and wage rate provisions under the Davis-Bacon Act, affecting oversight of contractor payments.
  • Recommended Follow-Up: Implement internal controls to ensure weekly certified payrolls are collected and wage rate provisions are included in all relevant contracts.

Finding Text

Identification of the federal program U.S. Department of Commerce Economic Development Cluster Assistance Listing Number 11.307 Economic Adjustment Assistance Federal Award Number – 08-79-05441 Award Period – 7/12/2021 – 7/11/2026 Criteria or specific requirement (including statutory, regulatory, or other citation) 2 CFR 200.303(a) requires that a non-federal entity must “(a) establish and maintain effective internal control over the Federal award that provides reasonable assurance that the non-Federal entity is managing the Federal award in compliance with Federal statutes, regulations, and the terms and conditions of the Federal award. These internal controls should be in compliance with guidance in “Standards for Internal Control in the Federal Government” issued by the Comptroller General of the United States and the “Internal Control Integrated Framework”, issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).”   Criteria or specific requirement (including statutory, regulatory, or other citation) (continued) Per the May 2023 OMB Compliance Supplement, “All laborers and mechanics employed by contractors or subcontractors to work on construction contracts in excess of $2,000 financed by federal assistance funds must be paid wages not less than those established for the locality of the project (prevailing wage rates) by the Department of Labor (DOL) (40 USC 3141–3144, 3146, and 3147. Nonfederal entities shall include in their construction contracts subject to the Wage Rate Requirements (which still may be referenced as the Davis-Bacon Act) a provision that the contractor or subcontractor comply with those requirements and the DOL regulations (29 CFR Part 5, Labor Standards Provisions Applicable to Contacts Governing Federally Financed and Assisted Construction). This includes a requirement for the contractor or subcontractor to submit to the nonfederal entity weekly, for each week in which any contract work is performed, a copy of the payroll and a statement of compliance (certified payrolls) (29 CFR sections 5.5 and 5.6; the A-102 Common Rule (section 36(i)(5)); OMB Circular A-110 (2 CFR Part 215, Appendix A, Contract Provisions); 2 CFR Part 176, Subpart C; and 2 CFR section 200.326). This reporting is often done using Optional Form WH-347, which includes the required statement of compliance (OMB No. 1235-0008).” Condition Texas Biomed did not obtain the required weekly certified payrolls from contractors and subcontractors for each week in which work was performed. Texas Biomed did not include the required provision that the contractor or subcontractor comply with the wage rate requirements in 1 of 5 selected construction contracts. Cause Texas Biomed did not have effective internal controls and procedures in place to ensure Texas Biomed complied with wage rate requirements. Effect or potential effect Texas Biomed did not comply with the wage rate requirements noted above. As a result, Texas Biomed did not have the ability to review required certified payroll reports to ensure contractors and subcontractors are paying prevailing wage rates. Questioned costs None. Context EY selected and tested 5 of 28 contractors and subcontractors in relation to the Economic Development Cluster. For 3 contractors/subcontractors, Texas Biomed did not obtain certified payrolls. For 2 contractors/subcontractors, Texas Biomed obtained minimal certified payrolls which did not cover the period in which work was performed. Texas Biomed did not include the required provision that the contractor or subcontractor comply with the wage rate requirements in 1 of 5 selected construction contracts. All of the expenditures for the Economic Development Cluster were for construction costs, including the $4,000,000 federal grant and Texas Biomed’s $6,000,000 match. Identification as a repeat finding, if applicable This is not a repeat finding. Recommendation We recommend Texas Biomed design and implement internal controls to ensure weekly certified payrolls are obtained from contractors and subcontractors and the required wage rate provisions are included in contracts for federally funded construction grants, as required. Views of responsible officials Management agrees with the finding and will implement controls to ensure compliance with Wage Rate Requirements.

Corrective Action Plan

The award subject to this finding was a novel award for Texas Biomed and, therefore, controls relative to the wage rate requirements were not in place. Texas Biomed relied on the general contractor awarded the construction project to facilitate compliance with the special tests and provisions; however, failed to validate that certified payrolls were provided as required. Texas Biomed has since implemented enhanced procedures and controls. Purchasing will ensure contracts subject to Davis Bacon Act requirements will clearly outline the responsibilities of the general contractor, as well as requiring flow down to subcontractors. For the Animal Care Complex project partially funded by the EDA award, Purchasing will request certified payrolls dating back to the start of the project from the contractor and subcontractors. Certified Payrolls will only be accepted via DOL form WH347. Texas Biomed has engaged an external project management firm to support extensive new construction underway or soon to commence on Texas Biomed’s campus. The consultant, as part of the scope of their engagement, will serve as the first reviewer of invoices and pay apps, and payment requests will not progress without their approval. The review will include verification of inclusion of necessary certified payrolls. Documentation will be saved in a shared Dropbox folder, where Texas Biomed Facilities personnel will review and sign off on the cover letter from the consultant, verifying Texas Biomed’s review of the necessary certified payrolls at that time. When the pay app is entered by Texas Biomed Accounts Payable in the automated system for invoice payment, the payment request will automatically route to a designated Texas Biomed Facilities staff member. This second staff member will provide a final review of the certified payrolls as a condition for approving the invoice for payment. Both Facilities staff members will have access to the certified payrolls and approval at each step will signify the necessary documentation has been received. If there is a lack of proper documentation, Facilities personnel will alert Accounts Payable of the reason for delay. Facilities personnel will follow up with the project management consultant and contractor to request additional backup when necessary. Responsible Parties: Amber Garcia, Facilities Operations Coordinator; Mike Merz, Principal Engineer; Patricia Thompson, Assistant Director, Materials Management Completion Date: December 31, 2024

Categories

Matching / Level of Effort / Earmarking Reporting

Other Findings in this Audit

  • 496802 2023-001
    Significant Deficiency Repeat
  • 496803 2023-001
    Significant Deficiency Repeat
  • 496804 2023-001
    Significant Deficiency Repeat
  • 496805 2023-001
    Significant Deficiency Repeat
  • 496806 2023-001
    Significant Deficiency Repeat
  • 496807 2023-001
    Significant Deficiency Repeat
  • 496808 2023-002
    Significant Deficiency
  • 496809 2023-002
    Significant Deficiency
  • 496810 2023-002
    Significant Deficiency
  • 496811 2023-002
    Significant Deficiency
  • 496812 2023-002
    Significant Deficiency
  • 496813 2023-002
    Significant Deficiency
  • 496814 2023-002
    Significant Deficiency
  • 496815 2023-002
    Significant Deficiency
  • 496817 2023-004
    Significant Deficiency
  • 1073244 2023-001
    Significant Deficiency Repeat
  • 1073245 2023-001
    Significant Deficiency Repeat
  • 1073246 2023-001
    Significant Deficiency Repeat
  • 1073247 2023-001
    Significant Deficiency Repeat
  • 1073248 2023-001
    Significant Deficiency Repeat
  • 1073249 2023-001
    Significant Deficiency Repeat
  • 1073250 2023-002
    Significant Deficiency
  • 1073251 2023-002
    Significant Deficiency
  • 1073252 2023-002
    Significant Deficiency
  • 1073253 2023-002
    Significant Deficiency
  • 1073254 2023-002
    Significant Deficiency
  • 1073255 2023-002
    Significant Deficiency
  • 1073256 2023-002
    Significant Deficiency
  • 1073257 2023-002
    Significant Deficiency
  • 1073258 2023-003
    Material Weakness
  • 1073259 2023-004
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
11.307 Economic Adjustment Assistance $4.00M
12.351 Basic Scientific Research - Combating Weapons of Mass Destruction $2.37M
93.352 Construction Support $1.62M
93.283 Centers for Disease Control and Prevention_investigations and Technical Assistance $784,471
93.RD Strong Heart Study Coordinating Center $517,217
93.859 Biomedical Research and Research Training $246,440
93.RD Niaid Centers of Excellence for Influenza Research and Response $221,347
93.360 Biomedical Advanced Research and Development Authority (barda), Biodefense Medical Countermeasure Development $130,082
93.839 Blood Diseases and Resources Research $119,768
93.865 Child Health and Human Development Extramural Research $89,708
93.286 Discovery and Applied Research for Technological Innovations to Improve Human Health $75,917
93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders $51,715
93.866 Aging Research $47,350
93.351 Research Infrastructure Programs $45,113
93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research $44,530
93.855 Allergy, Immunology and Transplantation Research $41,736
93.RD In Vitro and in Vivo Study of Roc-325 and Its Analogs in Live Sars-Cov-2 Models $36,205
93.242 Mental Health Research Grants $34,239
12.RD Test Support to the Battelle Accelerated Therapeutics for Combating Acute Viral Epidemics (bat-Cave) Program $29,333
93.RD Strong Heart Study (shs) Core Study Operations Coordinating Center Task Area B $28,986
93.279 Drug Abuse and Addiction Research Programs $26,432
93.838 Lung Diseases Research $10,624
12.420 Military Medical Research and Development $6,985
93.143 Niehs Superfund Hazardous Substances_basic Research and Education $5,952
93.350 National Center for Advancing Translational Sciences $5,619
93.113 Environmental Health $3,779
10.001 Agricultural Research_basic and Applied Research $2,548